BuyCancerDrugs.com BuyCancerDrugs.com
BuyCancerDrugs.com BuyCancerDrugs.com
OncologyJournal.org - The Latest Medical News and Information for Patients Diagnosed with Cancer
Search OncologyJournal.org
Browse by Cancer Type or Cancer Drug

Go Back   OncologyJournal.org - The Latest Medical News and Information for Patients Diagnosed with Cancer > Blogs > admin
Connect with Facebook


Fluorouracil
Old

Drug Shows Life-Saving Potential in Treating Toxicity of Widely Used Cancer Chemo.

Posted 05-21-2010 at 03:31 PM by admin
Wellstat Investigational Drug Shows Life-Saving Potential in Treating Toxicity of Widely Used Cancer Chemotherapy

May 20, 2010 06:00 PM Eastern Daylight Time

Presentation At ASCO Annual Meeting Will Report On Data For Uridine Triacetate To Reverse 5-FU Overexposure

GAITHERSBURG, Md.--(BUSINESS WIRE)--Wellstat Therapeutics announced today that the company’s investigational drug uridine triacetate has further demonstrated its life-saving potential in treating...
Administrator
Comments 0 admin is offline
Old

Oncolytics Biotech(R) Inc. Announces Phase I Colorectal Cancer Study

Posted 05-19-2010 at 08:20 PM by admin
CALGARY, May 19 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that following submission to the U.S. Food and Drug Administration (FDA) for review, the Company is initiating a U.S. Phase I study of REOLYSIN(R) in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + Irinotecan) in patients with oxaliplatin refractory/intolerant Kras mutant colorectal cancer (REO 022). The principal investigator is Dr. Sanjay...
Administrator
Comments 0 admin is offline
Old

Genta’s Tesetaxel Granted Fast Track Designation by FDA for Advanced Gastric Cancer

Posted 04-08-2010 at 03:58 PM by admin
April 06, 2010 08:05 AM Eastern Daylight Time

BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Genta Incorporated (OTCBB: GETA.OB) today announced that the U.S. Food and Drug Administration (FDA) has granted the Company’s request for “Fast Track” designation of tesetaxel for treatment of patients with advanced gastric cancer. Tesetaxel -- a late Phase 2 oncology product -- is the leading oral taxane currently in clinical development.

Fast Track designation is designed to facilitate...
Administrator
Comments 0 admin is offline
Old

Researchers Develop Method To Improve Cancer Treatments

Posted 10-27-2009 at 02:40 PM by admin
Medical News Today
Article Date: 23 Oct 2009 - 3:00 PDT

Cancer patients don't have time to waste, yet many must endure a tedious process of elimination as physicians try several different treatments until identifying the one that is most effective against their particular type of tumor. Now researchers at the University of Virginia Health System have developed a breakthrough method that could one day eliminate this trial and error approach to treating many cancers.

...
Administrator
Comments 0 admin is offline
Old

Harnessing the Biological Activity of Natural Products

Posted 09-29-2009 at 04:55 PM by admin
National Cancer Institute
NCI Cancer Bulletin
September 22, 2009 • Volume 6 / Number 18


Many herbs, dietary supplements, and even vitamins are suspected of interfering with chemotherapy and radiation therapy, and doctors now routinely advise patients who are undergoing cancer treatment to avoid taking these products.

At the same time, cancer researchers have been intrigued by the potent and beneficial biological activity shown by some natural products...
Administrator
Comments 0 admin is offline


All times are GMT. The time now is 12:53 AM.


Powered by vBulletin® Version 3.8.1
Copyright ©2000 - 2010, Jelsoft Enterprises Ltd.